Physician profile
Troy Lam
NPI 1851706048
$994.22
in general payments reported to CMS, 2019-2025
8 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $41.95 · 2021: $337 · 2022: $354 · 2024: $21.58 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $544.66 | 2021-2025 | |
| Stryker Corporation | $192.57 | 2021-2025 | Smartlock |
| Depuy Synthes Sales INC. | $133.14 | 2021-2022 | |
| Straumann USA LLC | $40.38 | 2024-2025 | |
| Dentsply Sirona INC | $30.85 | 2020-2022 | |
| Merz North America, INC. | $24.81 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.03 | 2022 | |
| Integra Lifesciences Corporation | $13.78 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.